Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
Cardiol Young ; 32(3): 503-505, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34378501

ABSTRACT

Neonatal aortic thrombus is a rare and critical condition that can present mimicking severe coarctation of the aorta or interrupted aortic arch. Transcatheter thrombectomy for this lesion has not been well described. We report a premature neonate with an occlusive proximal descending aorta thrombus, who underwent transcatheter mechanical thrombectomy using an Amplatzer Piccolo PDA occluder (Abbott, North Chicago, IL, USA). The procedure was successful with no subsequent distal thromboembolic events.


Subject(s)
Aortic Coarctation , Ductus Arteriosus, Patent , Septal Occluder Device , Thromboembolism , Thrombosis , Cardiac Catheterization , Ductus Arteriosus, Patent/surgery , Humans , Infant, Newborn , Thrombectomy/methods , Thrombosis/diagnostic imaging , Thrombosis/surgery , Treatment Outcome
3.
Pediatr Cardiol ; 39(2): 365-374, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29094192

ABSTRACT

Hematopoietic stem cell transplant (HSCT) is a therapeutic option for patients with sickle cell disease (SCD) and severe acquired aplastic anemia (SAA). HSCT may have beneficial effects on ventricular function in damaged myocardium. We hypothesized improvement in ventricular performance and pulmonary hypertension following HSCT with strain echocardiography in SCD and SAA. Echocardiographic strain and other standard functional data were obtained via retrospective cohort analysis of patients (n = 23) with SCD and SAA who underwent HSCT and were followed at a single center between 2000 and 2014. Left ventricular global longitudinal strain was below normal at baseline, and decreased significantly (from - 16.6 to - 11.1, P = 0.05) from pre-HSCT to the initial post-HSCT echocardiogram at 109 (SD ± 83) days. At 351 (SD ± 115) days, longitudinal strain improved significantly from initial decline (from - 11.1 to - 17.5, P = 0.009) but was comparable to baseline (P = 0.43). Other measurements of bi-ventricular function did not change significantly. Tricuspid regurgitation velocities as surrogates for pulmonary hypertension improved in the subset of patients with baseline elevated values although data points were limited. Abnormal myocardial systolic function was detected at baseline with strain imaging. HSCT was associated with initial worsening longitudinal strain values, followed by improvement to baseline levels by 1 year. Insufficient data exist on whether pulmonary hypertension improves after HSCT.


Subject(s)
Anemia, Aplastic/surgery , Anemia, Sickle Cell/surgery , Echocardiography/methods , Hematopoietic Stem Cell Transplantation/methods , Hypertension, Pulmonary/physiopathology , Ventricular Function/physiology , Adolescent , Anemia, Aplastic/physiopathology , Anemia, Sickle Cell/physiopathology , Child , Child, Preschool , Cohort Studies , Female , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Hypertension, Pulmonary/diagnostic imaging , Male , Retrospective Studies , Tricuspid Valve Insufficiency/complications
4.
Congenit Heart Dis ; 10(2): E43-7, 2015.
Article in English | MEDLINE | ID: mdl-24965688

ABSTRACT

OBJECTIVE: To determine if lower starting pulse fluoroscopy rates lead to lower overall radiation exposure without increasing complication rates or perceived procedure length or difficulty. SETTING: The pediatric cardiac catheterization laboratory at University of Michigan Mott Children's Hospital. PATIENTS: Pediatric patients with congenital heart disease. DESIGN/INTERVENTIONS: We performed a single-center quality improvement study where the baseline pulse fluoroscopy rate was varied between cases during pediatric cardiac catheterization procedures. OUTCOME MEASURES: Indirect and direct radiation exposure data were collected, and the perceived impact of the fluoroscopy rate and procedural complications was recorded. These outcomes were then compared among the different set pulse fluoroscopy rates. RESULTS: Comparing pulse fluoroscopy rates of 15, 7.5, and 5 frames per second from 61 cases, there was a significant reduction in radiation exposure between 15 and 7.5 frames per second. There was no difference in perceived case difficulty, procedural length, or procedural complications regardless of starting pulse fluoroscopy rate. CONCLUSIONS: For pediatric cardiac catheterizations, a starting pulse fluoroscopy rate of 7.5 frames per second exposes physicians and their patients to significantly less radiation with no impact on procedural difficulty or outcomes. This quality improvement study has resulted in a significant practice change in our pediatric cardiac catheterization laboratory, and 7.5 frames per second is now the default fluoroscopy rate.


Subject(s)
Cardiac Catheterization/methods , Cardiac Catheterization/standards , Fluoroscopy/methods , Heart Defects, Congenital/diagnosis , Radiation Exposure/prevention & control , Adolescent , Child , Child, Preschool , Health Facilities , Humans , Infant , Quality Improvement , Radiation Dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...